Evidence map›Paper›PMID 36355096›Full record

ArticleMetabolites2022

Network Pharmacology- and Molecular Dynamics Simulation-Based Bioprospection of

Ayesha Akoonjee, Athika Rampadarath, Christiana Eleojo Aruwa, Taibat Arinola Ajiboye, Abdulwakeel Ayokun-Nun Ajao, Saheed Sabiu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Jiangtang Decoction for Type 2 Diabetes and NAFLD: Integrative AnalysisEndocrine, metabolic & immune disorders drug targets · 2026
    Article
  2. Article
  3. Mechanistic Exploration ofBioMed research international · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ayesha AkoonjeeDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4000, South Africa.
Athika RampadarathDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4000, South Africa.
Christiana Eleojo AruwaDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4000, South Africa.
Taibat Arinola AjiboyeDepartment of Biochemistry, University of Abuja, Abuja 900105, Nigeria.
Abdulwakeel Ayokun-Nun AjaoDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4000, South Africa.ORCID 0000-0003-3820-2559
Saheed SabiuDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4000, South Africa.ORCID 0000-0001-7209-9220
Durban University of Technology · ZAUniversity of Abuja · NG

Funding

Durban University of Technology NANational Research Foundation 120433South African Medical Research Council NA
6 · The paper itself

Abstract

The medicinal herb

Indexed as

anti-diabetic activityAspalathus linearismolecular dynamics simulationnetwork pharmacologyrooibostype 2 diabetes

Identifiers

PMID36355096
PMCPMC9692680
OpenAlexW4307261860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.